Guy-Charles Fanneau de la Horie
Direttore/Membro del Consiglio presso GENFLOW BIOSCIENCES PLC
Patrimonio netto: 9 861 $ in data 30/06/2024
Posizioni attive di Guy-Charles Fanneau de la Horie
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GENFLOW BIOSCIENCES PLC | Direttore/Membro del Consiglio | 29/06/2022 | - |
| Independent Dir/Board Member | 29/06/2022 | - | |
| PHARNEXT SCA | Direttore/Membro del Consiglio | 10/07/2023 | - |
Storia della carriera di Guy-Charles Fanneau de la Horie
Precedenti posizioni note di Guy-Charles Fanneau de la Horie
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PHERECYDES PHARMA | Amministratore Delegato | 01/04/2016 | 19/05/2022 |
| NEOVACS | Direttore/Membro del Consiglio | 22/09/2011 | 17/10/2013 |
| Amministratore Delegato | 11/04/2007 | 17/10/2013 | |
PathoQuest SAS
 PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Amministratore Delegato | - | - |
| NANOBIOTIX | Direttore/Membro del Consiglio | - | - |
Formazione di Guy-Charles Fanneau de la Horie
| INSEAD | Masters Business Admin |
Statistiche
Distribuzione geografica
| Francia | 7 |
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| NEOVACS | Health Technology |
| NANOBIOTIX | Health Technology |
| GENFLOW BIOSCIENCES PLC | Health Technology |
| PHARNEXT SCA | Health Technology |
| Aziende private | 2 |
|---|---|
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Health Technology |
